Submission Details
| 510(k) Number | K241332 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 10, 2024 |
| Decision Date | September 20, 2024 |
| Days to Decision | 133 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K241332 is an FDA 510(k) clearance for the aprevo? anterior and lateral lumbar interbody fusion device; aprevo? anterior lumbar interbody fusion devices with interfixation; aprevo? transforaminal lumbar interbody fusion device, a Intervertebral Fusion Device With Bone Graft, Lumbar (Class II — Special Controls, product code MAX), submitted by Carlsmed, Inc. (Carlsbad, US). The FDA issued a Cleared decision on September 20, 2024, 133 days after receiving the submission on May 10, 2024. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3080.
| 510(k) Number | K241332 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 10, 2024 |
| Decision Date | September 20, 2024 |
| Days to Decision | 133 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | MAX — Intervertebral Fusion Device With Bone Graft, Lumbar |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3080 |
| Definition | Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft. |